Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab : LIBERTY ASTHMA TRAVERSE Study

Gurnell, MarkDomingo, ChristianRabe, Klaus FMenzies-Gow, AndrewPrice, DavidBrusselle, GuyWechsler, Michael EXia, ChangmingPandit-Abid, NamiGall, RebeccaJacob-Nara, Juby A.Rowe, Paul J.Deniz, YamoSiddiqui, Shahid2023-06-302023-06-302023Gurnell, M, Domingo, C, Rabe, K F, Menzies-Gow, A, Price, D, Brusselle, G, Wechsler, M E, Xia, C, Pandit-Abid, N, Gall, R, Jacob-Nara, J A, Rowe, P J, Deniz, Y & Siddiqui, S 2023, 'Sustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab : LIBERTY ASTHMA TRAVERSE Study', Allergy: European Journal of Allergy and Clinical Immunology, vol. 78, no. S111, 001590, pp. 237. https://doi.org/10.1111/all.156160105-4538https://hdl.handle.net/2164/210741179437engSDG 3 - Good Health and Well-beingR MedicineRSustained Improvement in Clinical Efficacy, Asthma Control, and Quality of Life in Patients With Severe, Oral Corticosteroid (OCS)-Dependent Asthma Treated With Dupilumab : LIBERTY ASTHMA TRAVERSE StudyJournal item10.1111/all.1561678